On the heels of the $4.85 Billion Vioxx settlement, the Multi-District Litigation (MDL) Court for the Bextra/Celebrex litigation has set the first Bextra trial for May 5, 2008.

The US Food and Drug Administration (FDA) has informed healthcare professionals about reports of suicidal thoughts as well as some aggressive and erratic behavior in patients who have taken varenicline (Chantix, Pfizer), a smoking cessation product.